Atom Investors LP Dexcom Inc Transaction History

Atom Investors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $364,133 - $463,625	3,301 Added 48.28%	10,138 $1.15 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $251,855 - $308,920	2,205 Added 47.6%	6,837 $948,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $349,669 - $575,109	4,632 New	4,632 $574,000
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $209,508 - $280,687	-2,686 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $256,539 - $303,383	2,686 New	2,686 $1.11 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $70,633 - $111,781	-1,478 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $512 - $802	14 Added 0.96%	1,478 $323,000
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $15,810 - $19,491	-445 Reduced 23.31%	1,464 $218,000
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $53,146 - $74,298	1,909 New	1,909 $286,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.